These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6113276)

  • 1. Long-acting parenteral drug formulations.
    Chien YW
    J Parenter Sci Technol; 1981; 35(3):106-39. PubMed ID: 6113276
    [No Abstract]   [Full Text] [Related]  

  • 2. Injection method for delivery of long-acting narcotic antagonists.
    Leafe TD; Sarner SF; Woodland JH; Yolles S; Blake DA; Meyer FJ
    Adv Biochem Psychopharmacol; 1973; 8(0):569-75. PubMed ID: 4794963
    [No Abstract]   [Full Text] [Related]  

  • 3. Narcotic antagonists: the search for long-acting preparations: introduction.
    Willette RE
    Natl Inst Drug Abuse Res Monogr Ser; 1975; (4):1-5. PubMed ID: 827708
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the effects of different routes of antipsychotic administration on pharmacokinetics and pharmacodynamics.
    Ereshefsky L; Mascarenas CA
    J Clin Psychiatry; 2003; 64 Suppl 16():18-23. PubMed ID: 14680415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-acting injectable antipsychotic agents.
    Drug Ther Bull; 1979 May; 17(11):41-3. PubMed ID: 38094
    [No Abstract]   [Full Text] [Related]  

  • 6. Advances in psychotropic formulations.
    Keith S
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):996-1008. PubMed ID: 16678954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone.
    Dunbar JL; Turncliff RZ; Dong Q; Silverman BL; Ehrich EW; Lasseter KC
    Alcohol Clin Exp Res; 2006 Mar; 30(3):480-90. PubMed ID: 16499489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-acting injectable naltrexone for the treatment of alcohol dependence.
    Mannelli P; Peindl K; Masand PS; Patkar AA
    Expert Rev Neurother; 2007 Oct; 7(10):1265-77. PubMed ID: 17939765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risperidone long-acting injection in practice - more questions than answers?
    Taylor D
    Acta Psychiatr Scand; 2006 Jul; 114(1):1-2. PubMed ID: 16774654
    [No Abstract]   [Full Text] [Related]  

  • 10. Design consideration for long-acting antagonists.
    Archer S
    Adv Biochem Psychopharmacol; 1973; 8(0):549-53. PubMed ID: 4368570
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical review of a long-acting, injectable formulation of risperidone.
    Knox ED; Stimmel GL
    Clin Ther; 2004 Dec; 26(12):1994-2002. PubMed ID: 15823763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An atypical long-acting injectable antipsychotic: implications for pharmacotherapy of schizophrenia.
    Dursun S
    J Psychopharmacol; 2005 Sep; 19(5 Suppl):3-4. PubMed ID: 16144780
    [No Abstract]   [Full Text] [Related]  

  • 13. Biodegradable drug delivery systems based on aliphatic polyesters: application to contraceptives and narcotic antagonists.
    Pitt CG; Marks TA; Schindler A
    NIDA Res Monogr; 1981; 28():232-53. PubMed ID: 6791007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Morphological study of the human ovary under the effect of injectable long-acting progestational hormones].
    Antonio Bocaz J; Feldman J; García Huidobro M; Gómez C; Guerrero R; Hasbun J; Lehrer N; Martínez L; Méndez G; Noriega C; Onetto E; Puga J; Pupkin M; Rodríguez R; Rosenberg D; Stone S; Zañartu J; Altieri E; Barsby F; Pérez I; Vega S
    Rev Chil Obstet Ginecol; 1970; 35(3):105-15. PubMed ID: 5508780
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical guidelines: Dosing and switching strategies for long-acting risperidone.
    Marder SR; Conley R; Ereshefsky L; Kane JM; Turner MS
    J Clin Psychiatry; 2003; 64 Suppl 16():41-6. PubMed ID: 14680418
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative efficacy and safety of long-acting risperidone and risperidone oral tablets.
    Chue P; Eerdekens M; Augustyns I; Lachaux B; Molcan P; Eriksson L; Pretorius H; David AS
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):111-7. PubMed ID: 15572280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
    Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
    J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia.
    Johnson DA
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):13-21. PubMed ID: 6143743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The depot paradox.
    Glazer WM
    Behav Healthc; 2007 May; 27(5):44-6. PubMed ID: 17958249
    [No Abstract]   [Full Text] [Related]  

  • 20. New drug development in France and French-speaking countries. Short and long acting neuroleptics.
    Deniker P; Ginestet D; Peron-Magnan P
    Dis Nerv Syst; 1974 Jul; 35(7 Pt. 2):18-20. PubMed ID: 17894096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.